Lyell Immunopharma CFO Charles Newton resigns effective Oct 31, 2025

Lyell Immunopharma, Inc.

Charles Newton resigns as CFO and principal financial/accounting officer, effective October 31, 2025.
No disagreements cited; Newton may provide consulting services through April 30, 2026.
Company plans to conduct a search for a new CFO; no replacement named yet.

item 5.02

Lyell Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-205020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.